Alnylam Pharmaceuticals Inc (STU:DUL)
€ 190.4 +3.65 (+1.95%) Market Cap: 25.64 Bil Enterprise Value: 23.87 Bil PE Ratio: 41.12 PB Ratio: 21.85 GF Score: 70/100
Sorry the transcript is not found. Please try another one.